The recovery proceedings against these entities -- Shivinder Mohan Singh, Malav Holdings, RHC Holding, ANR Securities and Religare Corporate Services (now known as Finserve Shared Services) -- for Rs 32.10 crore.
The case relates to the diversion of funds to the tune of Rs 2,473.66 crore of Religare Finvest Ltd (RFL), a subsidiary of Religare Enterprises Ltd (REL), during FY 2014-15 till FY 2017-18, in the garb of loans through layers of entities for the ultimate benefits of entities controlled by the erstwhile promoters -- Singh brothers.
Justice Mukta Gupta denied him the relief, saying Singh was allegedly involved in offences punishable with more than 7-year sentence and that too in more than one case and "hence does not qualify to be released" as per criteria laid down by a high powered committee.
The regulator has directed the two companies to 'initiate steps to recall all the loans amounting to Rs 2,315.09 crore' along with due interest within three months.
Shivinder had earlier on September 4 filed a case against Malvinder and Sunil Godhwani in the NCLT, alleging 'oppression and mismanagement' of RHC Holding, Religare Enterprises and Fortis Healthcare.
While Malvinder Mohan Singh has become non-Executive Chairman, his younger brother Shivinder has been designated as non-executive Vice Chairman with effect from July 29, the company said in a regulatory filing.
Shivinder Mohan Singh (40), who is the co-founder of the healthcare chain will become the Non-Executive Vice-Chairman with effect from January 1, 2016, the company said in a statement.
Fortis Healthcare Thursday reported a consolidated net profit of Rs 87.28 crore for the first quarter ended June 30, 2015-16, mainly on account of gains from divestment of international businesses.
"The reported results for Q1FY16 are not comparable to the corresponding previous period due to progressive divestments of company's international businesses namely RadLink Asia, Singapore and Fortis Surgical Hospital Singapore; the divestment of both being completed in Q1FY16," Fortis Healthcare said.
"It brings a lot of respect for the person in the cockpit. It is an extremely remunerative position to be in. We consciously try to ensure that more and more women get into the cockpit," SpiceJet Chairman Ajay Singh on Thursday said.
Facing arbitration claims here by Daiichi Sankyo, Ranbaxy's former Indian promoters are counting on 'representations and warranties' made in the share purchase agreement signed with the Indian drugmaker's current Japanese owners in 2008.
On September 30, 2013 Mehta & Mehta Real Estate Pvt Ltd bought 40,44,000 shares of Religare Enterprises at Rs 345.
On September 19, 2013 Malvinder Mohan Singh sold 60,41,875 shares of Religare Enterprises at Rs 352 Shivinder Mohan Singh sold 31,20,000 shares at Rs 352 on the NSE
Ranbaxy Laboratories was started by two Indians Ranjit Singh and Gurbax Singh. Ranbaxy pleaded guilty to felony charges related to drug safety and agreed to pay $500 million in civil and criminal fines under a settlement with the US Department of Justice.
Fortis Healthcare International, the Singapore-based holding company of India's billionaire Singh brothers, said on Wednesday it will buy a 65% stake in Vietnam's Hoan My Medical Corp for USD 64 million.
Fortis Healthcare (India) today said it will open 25 low cost hospitals in the next three years in smaller towns, specially in tier II and Tier III cities under a new brand as the firm completes a decade of operations.
Commenting on Fortis Healthcare's performance during the quarter, its managing director Shivinder Mohan Singh said, "We have set up three greenfield hospitals, adding 1,000 beds and expect to set up another 900 beds in the next one year."